Beximco Pharmaceuticals (LON:BXP) Stock Price Up 16.4% – Still a Buy?

by · The Cerbat Gem

Beximco Pharmaceuticals Limited (LON:BXP – Get Free Report)’s share price was up 16.4% during mid-day trading on Friday . The company traded as high as GBX 32 ($0.42) and last traded at GBX 32 ($0.42). Approximately 92,950 shares were traded during trading, a decline of 44% from the average daily volume of 167,168 shares. The stock had previously closed at GBX 27.50 ($0.36).

Beximco Pharmaceuticals Trading Up 16.4 %

The company has a debt-to-equity ratio of 14.73, a quick ratio of 0.37 and a current ratio of 1.80. The firm has a fifty day moving average price of GBX 27.15 and a 200 day moving average price of GBX 34.52. The company has a market cap of £142.76 million, a price-to-earnings ratio of 343.75 and a beta of 0.61.

About Beximco Pharmaceuticals

(Get Free Report)

Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies.

Further Reading